Cargando…
Particle radiotherapy for breast cancer
Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy co...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467264/ https://www.ncbi.nlm.nih.gov/pubmed/37655110 http://dx.doi.org/10.3389/fonc.2023.1107703 |
_version_ | 1785099077928615936 |
---|---|
author | Ruan, Hanguang Okamoto, Masahiko Ohno, Tatsuya Li, Yang Zhou, Yuan |
author_facet | Ruan, Hanguang Okamoto, Masahiko Ohno, Tatsuya Li, Yang Zhou, Yuan |
author_sort | Ruan, Hanguang |
collection | PubMed |
description | Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy complications should not be overlooked. Common complications include dose-related coronary toxicity, radiation pneumonia, and the risk of second primary cancer of the contralateral breast. Particle radiotherapy with protons or carbon ions is widely attracting interest as a potential competitor to conventional photon radiotherapy because of its superior physical and biological characteristics. This article summarizes the results of clinical research on proton and carbon-ion radiotherapy for treating breast cancer |
format | Online Article Text |
id | pubmed-10467264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104672642023-08-31 Particle radiotherapy for breast cancer Ruan, Hanguang Okamoto, Masahiko Ohno, Tatsuya Li, Yang Zhou, Yuan Front Oncol Oncology Breast cancer is the most common malignant tumor in female patients. Along with surgery, radiotherapy is one of the most commonly prescribed treatments for breast cancer. Over the past few decades, breast cancer radiotherapy technology has significantly improved. Nevertheless, related posttherapy complications should not be overlooked. Common complications include dose-related coronary toxicity, radiation pneumonia, and the risk of second primary cancer of the contralateral breast. Particle radiotherapy with protons or carbon ions is widely attracting interest as a potential competitor to conventional photon radiotherapy because of its superior physical and biological characteristics. This article summarizes the results of clinical research on proton and carbon-ion radiotherapy for treating breast cancer Frontiers Media S.A. 2023-08-16 /pmc/articles/PMC10467264/ /pubmed/37655110 http://dx.doi.org/10.3389/fonc.2023.1107703 Text en Copyright © 2023 Ruan, Okamoto, Ohno, Li and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ruan, Hanguang Okamoto, Masahiko Ohno, Tatsuya Li, Yang Zhou, Yuan Particle radiotherapy for breast cancer |
title | Particle radiotherapy for breast cancer |
title_full | Particle radiotherapy for breast cancer |
title_fullStr | Particle radiotherapy for breast cancer |
title_full_unstemmed | Particle radiotherapy for breast cancer |
title_short | Particle radiotherapy for breast cancer |
title_sort | particle radiotherapy for breast cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467264/ https://www.ncbi.nlm.nih.gov/pubmed/37655110 http://dx.doi.org/10.3389/fonc.2023.1107703 |
work_keys_str_mv | AT ruanhanguang particleradiotherapyforbreastcancer AT okamotomasahiko particleradiotherapyforbreastcancer AT ohnotatsuya particleradiotherapyforbreastcancer AT liyang particleradiotherapyforbreastcancer AT zhouyuan particleradiotherapyforbreastcancer |